Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Monitoring literature for Benefit-Risk Evaluation: a Life-Time Responsibility

Posted on January 15th, 2016 by in Pharmacovigilance

Monitoring worldwide experience

The purpose of drugs is to cure or alleviate symptoms of disease. However, drugs do not only have therapeutic effects, they may also cause adverse drug reactions (ADRs). (more…)

Social Media Screening for ADR-monitoring – Like it or not!

Posted on December 16th, 2015 by in Pharmacovigilance

Social Media and Pharmacovigilance

Limitations of clinical trials and traditional post-marketing sources of safety information. 

Due to limitations of pre-marketing clinical trials, there isn’t much information available once a medicinal product is authorized for marketing. (more…)

  1. 1
  2. 3
  3. 4
  4. 5